New combo therapy targets hard-to-treat liver cancer
NCT ID NCT04238637
First seen Dec 10, 2025 · Last updated May 20, 2026 · Updated 18 times
Summary
This study tests whether adding immunotherapy drugs (durvalumab alone or with tremelimumab) to a type of internal radiation therapy (Y-90 SIRT) can shrink tumors in people with advanced bile duct cancer that has not spread beyond the liver. About 50 adults with this rare liver cancer will take part. The goal is to see if the combination improves response rates and is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAHEPATIC CHOLANGIOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinic Essen Center
Essen, Germany
-
Hannover Medical School
Hanover, Germany
-
Munich Clinic Bogenhausen
Munich, Germany
-
University Hospital Dresden
Dresden, Germany
-
University Hospital Essen
Essen, Germany
-
University Hospital Halle
Halle, Germany
-
University Hospital Jena
Jena, Germany
-
University Hospital Munich Grosshadern
Munich, Germany
Conditions
Explore the condition pages connected to this study.